Custom Recombinant Protein Production Services Market, By Expression System (Mammalian, Bacteria, Insect, Yeast, and Others), By End User (Research Institutes, Biotechnology and  Pharmaceutical Companies, Contract Research Organizations and Others), and

Custom Recombinant Protein Production Services Market, By Expression System (Mammalian, Bacteria, Insect, Yeast, and Others), By End User (Research Institutes, Biotechnology and  Pharmaceutical Companies, Contract Research Organizations and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Custom recombinant protein production is one of the efficient techniques used in life sciences that play a major role in advanced healthcare. Recombinant proteins have a wide range of applications in biotechnology, research, and medicine. Increasing funding in the field of life sciences is expected to accelerate growth of the custom recombinant protein production services market. The importance of recombinant protein for therapeutic application is increasing immensely. Various biopharmaceutical companies are focusing on research and development of novel biosimilars for life threatening diseases. Proteins are manipulated using specified techniques to derive recombinant proteins, these recombinant proteins are encoded by genes for the production of large quantities of protein. Recombinant proteins are further used for the manufacturing of therapeutic commercial products. Technological advancement in the production of recombinant protein is predicted to boost growth of the market.
Market Dynamics
Increasing funding and investments in the field of life sciences are expected to drive the market growth during the forecast period. For instance, additional funding of US$ 3.0 million was received by Oxford Protein Production Facility-UK from the Laboratory of Molecular Biology for providing a wide range of highly specialized technologies that incorporates robotic systems for high throughput purification, expression, and crystallization of recombinant proteins.
Key features of the study:
The report provides an in-depth analysis of the Custom Recombinant Protein Production Services market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the custom recombinant protein production services market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include GenScript Biotech Corporation, SignalChem Biotech Inc., Crown Bioscience, Inc., BPS Bioscience Inc., Novoprotein, Applied Biological Materials (abm) Inc., Eurofins Pharma Discovery Services, Abgent (WuXi AppTec Company), OriGene Technologies, Inc., Kempbio, Inc., Trenzyme GmbH, Sino Biological Inc., Aragen Bioscience, a GVKBIO Company, LakePharma, Inc., Proteos Inc., Icosagen AS, Novus Biological LLC, Proteogenix, Premas Biotech, ATUM, and Aldevron
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The custom recombinant protein production services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the custom recombinant protein production services market
Detailed Segmentation:
Custom Recombinant Protein Production Services Market, By Expression System:
Mammalian
Bacteria
Insect
Yeast
Others
Custom Recombinant Protein Production Services Market, By End User:
Research Institutes
Biotechnology and Pharmaceutical Companies
Contract Research Organizations
Others
Custom Recombinant Protein Production Services Market, By Region:
North America
By Expression System
Mammalian
Bacteria
Insect
Yeast
Others
, By End User
Research Institutes
Biotechnology and Pharmaceutical Companies
Contract Research Organizations
Others
By Country
U.S.
Canada
Latin America
By Expression System
Mammalian
Bacteria
Insect
Yeast
Others
, By End User
Research Institutes
Biotechnology and Pharmaceutical Companies
Contract Research Organizations
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Expression System
Mammalian
Bacteria
Insect
Yeast
Others
, By End User
Research Institutes
Biotechnology and Pharmaceutical Companies
Contract Research Organizations
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Expression System
Mammalian
Bacteria
Insect
Yeast
Other
By End User
Research Institutes
Biotechnology and Pharmaceutical Companies
Contract Research Organizations
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Expression System
Mammalia
Bacteria
Insect
Yeast
Others
, By End User
Research Institutes
Biotechnology and Pharmaceutical Companies
Contract Research Organizations
Others
By Country
GCC
Israel
Rest of Middle East
Africa
By Expression System
Mammalian
Bacteria
Insect
Yeast
Others
, By End User
Research Institutes
Biotechnology and Pharmaceutical Companies
Contract Research Organizations
Others
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
GenScript Biotech Corporation *
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
SignalChem Biotech Inc.
Crown Bioscience, Inc.
BPS Bioscience Inc.
Novoprotein
Applied Biological Materials (abm) Inc.
Eurofins Pharma Discovery Services
Abgent (WuXi AppTec Company)
OriGene Technologies, Inc.
Kempbio, Inc.,
Trenzyme GmbH
Sino Biological Inc.
Aragen Bioscience, a GVKBIO Company
LakePharma, Inc.
Proteos, Inc.
Icosagen AS
Novous Biologicals LLC
Proteogenix
Premas Biotech
ATUM
Aldevron
“*” marked represents similar segmentation in other categories in the respective section.